Court Sides With FTC in Pay-For-Delay Suit, Says AbbVie Patent Suits Were Baseless

Drug Industry Daily
A A
A federal judge in Pennsylvania threw out AbbVie’s patent suits against generic competitors, strengthening the Federal Trade Commission’s pay-for-delay case against the drugmaker.

To View This Article:

Login

Subscribe To Drug Industry Daily